Study of AZD8931 in Patients With Advanced Solid Malignancies

NCT00637039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: AZD8931

Sponsor

AstraZeneca